Editors’ declarations of interest

JOURNAL ARTICLE published January 2014 in Alimentary Pharmacology & Therapeutics

Commentary: demystifying IBS mind-based therapies

JOURNAL ARTICLE published August 2013 in Alimentary Pharmacology & Therapeutics

Authors: P. Paine

Exposure to hookworms in patients with Crohn’s disease: authors’ reply

JOURNAL ARTICLE published November 2011 in Alimentary Pharmacology & Therapeutics

Authors: B. S. Ramakrishna | H. J. Binder | V. Subramanian | S. Pugazhendhi | J. Kabeerdoss

Editorial: direct acting antivirals - not the be-all and end-all in HIV/HCV co-infection. Authors' reply

JOURNAL ARTICLE published February 2017 in Alimentary Pharmacology & Therapeutics

Authors: P. Schwabl | M. Mandorfer | T. Reiberger | the Vienna HIV & Liver Study Group and the Vienna Hepatic Hemodynamic Lab

Treatment of bloating and distension - role of probiotics: authors’ reply

JOURNAL ARTICLE published September 2011 in Alimentary Pharmacology & Therapeutics

Authors: M. Schmulson | L. Chang

Is liver stiffness measurement unreliable in obese patients?

JOURNAL ARTICLE published July 2011 in Alimentary Pharmacology & Therapeutics

Authors: V. W.-S. Wong | H. L.-Y. Chan

Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed‐release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis

JOURNAL ARTICLE published April 2009 in Alimentary Pharmacology & Therapeutics

Authors: D. C. METZ | C. W. HOWDEN | M. C. PEREZ | L. LARSEN | J. O’NEIL | S. N. ATKINSON

Review article: the genetics of the human leucocyte antigen region in inflammatory bowel disease

JOURNAL ARTICLE published October 2019 in Alimentary Pharmacology & Therapeutics

Authors: James J. Ashton | Katy Latham | Robert Mark Beattie | Sarah Ennis

Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial

JOURNAL ARTICLE published October 2000 in Alimentary Pharmacology & Therapeutics

Authors: P. J. Kahrilas | G. W. Falk | D. A. Johnson | C. Schmitt | D. W. Collins | J. Whipple | D. D'Amico | B. Hamelin | B. Joelsson | FOR THE ESOMEPRAZOLE STUDY INVESTIGATORS

Review article: anti‐diarrhoeal pharmacology and therapeutics

JOURNAL ARTICLE published April 1995 in Alimentary Pharmacology & Therapeutics

Authors: L. R. SCHILLER

Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease

JOURNAL ARTICLE published September 2022 in Alimentary Pharmacology & Therapeutics

Research funded by FP7 Health (305564)

Authors: Ashkan Rezazadeh Ardabili | Steven Jeuring | Zlatan Mujagic | Liekele Oostenbrug | Mariëlle Romberg‐Camps | Daisy Jonkers | Adriaan van Bodegraven | Marieke Pierik

Mucosal healing and a fall in mucosal pro‐inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn’s disease

JOURNAL ARTICLE published March 2000 in Alimentary Pharmacology & Therapeutics

Review article: bile acid therapy

JOURNAL ARTICLE published February 1990 in Alimentary Pharmacology & Therapeutics

Authors: A. LANZINI | T. C. NORTHFIELD

Letter: inflammatory bowel disease guidelines and conflicts of interest

JOURNAL ARTICLE published August 2013 in Alimentary Pharmacology & Therapeutics

Authors: R. Eliakim | A. Dignass | S. Travis

Letter: ciclosporin or infliximab in acute ulcerative colitis - still undecided; authors’ reply

JOURNAL ARTICLE published October 2013 in Alimentary Pharmacology & Therapeutics

Authors: A. Croft | A. Walsh | J. Doecke | G. Radford-Smith

JOURNAL ISSUE published December 2006 in Alimentary Pharmacology & Therapeutics

JOURNAL ISSUE published December 2010 in Alimentary Pharmacology & Therapeutics

A novel phenotype‐based drug‐induced liver injury causality assessment tool (DILI‐CAT) allows for signal confirmation in early drug development

JOURNAL ARTICLE published April 2022 in Alimentary Pharmacology & Therapeutics

Research funded by National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK 123704) | National Institutes of Health (P20 GM 130457)

Authors: Richard P. Hermann | Don C. Rockey | Ayako Suzuki | Michael Merz | Hans L. Tillmann

Letter: potential selection bias in the real‐world comparison of ustekinumab versus vedolizumab as a second‐line treatment for Crohn’s disease

JOURNAL ARTICLE published April 2022 in Alimentary Pharmacology & Therapeutics

Authors: Motohiko Adomi | Avik Ray

Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug‐induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis

JOURNAL ARTICLE published March 2019 in Alimentary Pharmacology & Therapeutics

Authors: Arie Regev | Melissa Palmer | Mark I. Avigan | Lara Dimick‐Santos | William R. Treem | John F. Marcinak | Daniel Seekins | Gopal Krishna | Frank A. Anania | James W. Freston | James H. Lewis | Arun J. Sanyal | Naga Chalasani